Andrea Corbacioglu
Impact in
- Hematology top 0.2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Genetics top 1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 21
- Acute Myeloid Leukemia Research 21
- Chronic Myeloid Leukemia Treatments 7
- Genetics 10
- Myeloproliferative Neoplasms: Diagnosis and Treatment 10
- Co-authors
- Konstanze Döhner (21 shared papers)Hartmut Döhner (20 shared papers)Richard F. Schlenk (20 shared papers)Lars Bullinger (16 shared papers)Stefan Fröhling (11 shared papers)Marianne Habdank (7 shared papers)Arnold Ganser (16 shared papers)Jürgen Krauter (11 shared papers)
- Journals
- Blood (17 papers)Journal of Clinical Oncology (3 papers)New England Journal of Medicine (1 paper)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Andrea Corbacioglu
21 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 58
- Hematology 2.4k
- Genetics 863
- Public Health, Environmental and Occupational Health 708
- Cancer Research 365
- Molecular Biology 1.3k
Countries citing papers authored by Andrea Corbacioglu
This map shows the geographic impact of Andrea Corbacioglu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Corbacioglu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Corbacioglu more than expected).
Fields of papers citing papers by Andrea Corbacioglu
This network shows the impact of papers produced by Andrea Corbacioglu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Corbacioglu. The network helps show where Andrea Corbacioglu may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrea Corbacioglu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia Hit paper breakdown → | 2008 | 1103 |
| 2 | Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations Hit paper breakdown → | 2005 | 603 |
| 3 | 2011 | 328 | |
| 4 | 2010 | 262 | |
| 5 | 2009 | 124 | |
| 6 | 2010 | 107 | |
| 7 | 2007 | 85 | |
| 8 | 2006 | 14 | |
| 9 | 2007 | 9 | |
| 10 | 2007 | 3 | |
| 11 | 2009 | 3 | |
| 12 | 2011 | 3 | |
| 13 | 2009 | 3 | |
| 14 | 2006 | 3 | |
| 15 | 2011 | 2 | |
| 16 | 2007 | 2 | |
| 17 | 2009 | 2 | |
| 18 | 2008 | 1 | |
| 19 | 2006 | 1 | |
| 20 | 2015 | 1 |
About Andrea Corbacioglu
Andrea Corbacioglu is a scholar working on Hematology, Genetics, Molecular Biology, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine, having authored 21 papers that have together received 2.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (21 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers), Chronic Myeloid Leukemia Treatments (7 papers), Protein Degradation and Inhibitors (4 papers), Retinoids in leukemia and cellular processes (3 papers), Histone Deacetylase Inhibitors Research (2 papers), Acute Lymphoblastic Leukemia research (2 papers) and Epigenetics and DNA Methylation (1 paper). The work is most often cited by research in Hematology (2.4k citations), Genetics (863 citations), Public Health, Environmental and Occupational Health (708 citations), Cancer Research (365 citations) and Molecular Biology (1.3k citations). Andrea Corbacioglu has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Konstanze Döhner, Hartmut Döhner, Richard F. Schlenk, Lars Bullinger, Stefan Fröhling, Marianne Habdank, Arnold Ganser, Jürgen Krauter, Brigitte Schlegelberger and Daniela Späth. Their work appears in journals such as Blood, Journal of Clinical Oncology and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.